Formaderm (Hyaluronic Acid) for Facial Soft Tissue Augmentation

Exclusion Criteria

• •Women subjects who are pregnant, breastfeeding, planning to become pregnant, and not willing to take contraception during the trial period.
• •Those who are emotionally unstable or suffering from a mental disease.
• •Those who have severe skin disease, inflammation, or related symptoms such as infections, psoriasis, herpes, and the like.
• •Those who have undergone cosmetic treatment or surgery prior to the trial:
• •Those who have undergone laser treatment or dermabrasion within the past 12 months.
• •Those who have undergone chemical peels treatment within the last three months.
• •Those who have undergone facial wrinkle augmentation surgery such as Botox injections within the past 12 months.
• •Those with silicone in their body or material that cannot be absorbed by the body (permanent filling agent).
• •Those who have undergone facial surgery or filing agent implants in the nasolabial fold area within the past 24 months.
• •Those who have a scar or localized infection in the nasolabial fold area.
• •Those with connective tissue diseases.
• •Those with diabetes or systemic disease that cannot be controlled.
• •Those suffering from human immunodeficiency syndrome.
• •Those suffering from immunity related disorder or have had immune system degradation in the past.
• •Those with a scar-prone constitution, prone to scar formation or hypertrophic scars.
• •Those who have joined other clinical trials such ass medical device related and other similar trials within the past six months.
• •Those with a medical history of cosmetic filling agent allergy, any type of hyaluronic acid implants, or drugs (such as antibiotics, antihistamine, non-steroidal anti-inflammatory analgesics), or those with a medical history of local anesthetic allergy.
• •Patients undergoing anticoagulant treatment, those who have a medical history of coagulation defects, or those taking Chinese medicine for promoting blood circulation.
• •Those whose medication and medical conditions are deemed unfit for inclusion in the research based on the judgment of the researcher.
• •Those who are unable to comply with re-visit schedule or are unwell to sign the informed consent.